[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2832710B1 - Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments - Google Patents

Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments

Info

Publication number
FR2832710B1
FR2832710B1 FR0115342A FR0115342A FR2832710B1 FR 2832710 B1 FR2832710 B1 FR 2832710B1 FR 0115342 A FR0115342 A FR 0115342A FR 0115342 A FR0115342 A FR 0115342A FR 2832710 B1 FR2832710 B1 FR 2832710B1
Authority
FR
France
Prior art keywords
sulfanyl
medicaments
triazoles
derivatives
triazoles derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0115342A
Other languages
English (en)
Other versions
FR2832710A1 (fr
Inventor
Marie Odile Galcera
Alban Sidhu
Pierre Roubert
Christophe Thurieau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0115342A priority Critical patent/FR2832710B1/fr
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to AU2002361345A priority patent/AU2002361345B8/en
Priority to CNB028276248A priority patent/CN100462359C/zh
Priority to HU0402489A priority patent/HUP0402489A3/hu
Priority to PCT/FR2002/004055 priority patent/WO2003045926A1/fr
Priority to KR1020047008002A priority patent/KR100961332B1/ko
Priority to MYPI20024450A priority patent/MY133406A/en
Priority to CA002468184A priority patent/CA2468184A1/fr
Priority to TW091134432A priority patent/TWI283670B/zh
Priority to BR0214553-7A priority patent/BR0214553A/pt
Priority to JP2003547378A priority patent/JP2005513035A/ja
Priority to US10/496,820 priority patent/US20050154039A1/en
Priority to PL02370140A priority patent/PL370140A1/xx
Priority to EP02796876A priority patent/EP1465880B1/fr
Priority to RU2004119406/04A priority patent/RU2367655C2/ru
Priority to NZ533397A priority patent/NZ533397A/en
Priority to DE60233265T priority patent/DE60233265D1/de
Priority to CZ2004760A priority patent/CZ2004760A3/cs
Priority to ES02796876T priority patent/ES2330927T3/es
Priority to AT02796876T priority patent/ATE438630T1/de
Priority to MXPA04005099A priority patent/MXPA04005099A/es
Priority to ARP020104601A priority patent/AR037465A1/es
Publication of FR2832710A1 publication Critical patent/FR2832710A1/fr
Priority to NO20042635A priority patent/NO20042635L/no
Publication of FR2832710B1 publication Critical patent/FR2832710B1/fr
Application granted granted Critical
Priority to HK05103025.8A priority patent/HK1070361A1/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0115342A 2001-11-28 2001-11-28 Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments Expired - Fee Related FR2832710B1 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR0115342A FR2832710B1 (fr) 2001-11-28 2001-11-28 Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments
MXPA04005099A MXPA04005099A (es) 2001-11-28 2002-11-27 Derivados de 5-sulfanil-4h-1,2,4-triazol y su uso como medicamento.
HU0402489A HUP0402489A3 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
PCT/FR2002/004055 WO2003045926A1 (fr) 2001-11-28 2002-11-27 Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicament
KR1020047008002A KR100961332B1 (ko) 2001-11-28 2002-11-27 5-술파닐-4ｈ-1,2,4-트리아졸 유도체 및 의약으로서 그의용도
MYPI20024450A MY133406A (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament
CA002468184A CA2468184A1 (fr) 2001-11-28 2002-11-27 Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicament
TW091134432A TWI283670B (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament
BR0214553-7A BR0214553A (pt) 2001-11-28 2002-11-27 Compostos, processo de preparação, em fase lìquida, dos compostos, e, composições farmacêuticas
JP2003547378A JP2005513035A (ja) 2001-11-28 2002-11-27 ５−スルファニル−４ｈ−１，２，４−トリアゾール誘導体及びその医薬としての使用
US10/496,820 US20050154039A1 (en) 2001-11-28 2002-11-27 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
PL02370140A PL370140A1 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
AU2002361345A AU2002361345B8 (en) 2001-11-28 2002-11-27 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as medicine
EP02796876A EP1465880B1 (fr) 2001-11-28 2002-11-27 Derives de 5-sulfanyl-4h-1,2,4-triazoles pour traiter les désordres associés à la somatostatine
AT02796876T ATE438630T1 (de) 2001-11-28 2002-11-27 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
DE60233265T DE60233265D1 (de) 2001-11-28 2002-11-27 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
CZ2004760A CZ2004760A3 (cs) 2001-11-28 2002-11-27 Deriváty 5-sulfanyl-4H-1,2,4-triazolů, způsob jejich přípravy a jejich použití jako léčivo
ES02796876T ES2330927T3 (es) 2001-11-28 2002-11-27 Derivados de 5-sulfanil-4h-1,2,4-triazoles para tratar trastornos asociados a la somatostatina.
NZ533397A NZ533397A (en) 2001-11-28 2002-11-27 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as a medicament
CNB028276248A CN100462359C (zh) 2001-11-28 2002-11-27 5-硫烷基-4h-1,2,4-三唑衍生物及其作为药物的应用
RU2004119406/04A RU2367655C2 (ru) 2001-11-28 2002-11-27 5-сульфанил-4н-1,2,4-триазольные производные и их применение в качестве лекарственного препарата
ARP020104601A AR037465A1 (es) 2001-11-28 2002-11-28 Compuesto derivado de 5-sulfanil-4h-1,2,4-triazol, composicion farmaceutica que lo comprende y proceso para su preparacion en fase liquida
NO20042635A NO20042635L (no) 2001-11-28 2004-06-23 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
HK05103025.8A HK1070361A1 (en) 2001-11-28 2005-04-11 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115342A FR2832710B1 (fr) 2001-11-28 2001-11-28 Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments

Publications (2)

Publication Number Publication Date
FR2832710A1 FR2832710A1 (fr) 2003-05-30
FR2832710B1 true FR2832710B1 (fr) 2004-09-03

Family

ID=8869847

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0115342A Expired - Fee Related FR2832710B1 (fr) 2001-11-28 2001-11-28 Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments

Country Status (1)

Country Link
FR (1) FR2832710B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE279396T1 (de) * 1998-06-12 2004-10-15 Sod Conseils Rech Applic Imidazolderivate und ihre verwendung als somatostatin rezeptorliganden
FR2796945B1 (fr) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament

Also Published As

Publication number Publication date
FR2832710A1 (fr) 2003-05-30

Similar Documents

Publication Publication Date Title
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
NO20014963L (no) Cycloalkyl-substituerte benzimidazoler, samt fremstilling og anvendelse derav
FR2802206B1 (fr) Derives de 4-aminopiperidine et leur utilisation en tant que medicament
DE69927946D1 (de) Verkalkungsbeständige medizinische artikel
DE69907964D1 (de) 1,2-annelierte chinolinderivate
NO20032909L (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
DE69824632D1 (de) Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
IT1308096B1 (it) Convertiplano
MA26599A1 (fr) Nouveaux derives de benzenesulfonyle, leur preparation et leur application en tant que medicament
ID29089A (id) Sediaan farmasi moksifloksasin
EE04236B1 (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
NO20014490D0 (no) Medisinske blandinger
ATE228510T1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
FR2806720B1 (fr) Derives de 2,2,6,6-diethyl-dimethyl-1-alcoxypiperidines et 1-oxydes correspondants
ATE315036T1 (de) 2,4-diaminopyrimidinderivate als immunosuppressiva
IS5730A (is) Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
DE60006958D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
ID30032A (id) Formulasi farmasi

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20120731